{
    "root": "92eaabb9-7dde-4153-9794-fa0f0b72b05f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Leuprolide Acetate",
    "value": "20250315",
    "ingredients": [],
    "indications": "leuprolide acetate injection indicated palliative treatment advanced prostatic cancer .",
    "contraindications": "recommended dose 1 mg ( 0.2 ml 20 unit mark ) administered single daily subcutaneous injection . drugs administered chronically subcutaneous injection , injection site varied periodically . 0.2 ml contains 1 mg leuprolide acetate , sodium chloride tonicity adjustment , 1.8 mg benzyl alcohol preservative water injection . ph may adjusted sodium hydroxide and/or acetic acid . follow pictorial directions reverse side package insert . note : parenteral products , inspect solution discoloration particulate matter .",
    "warningsAndPrecautions": "leuprolide acetate injection sterile solution supplied follows : leuprolide acetate injection ndc ( 1 mg per 0.2 ml ) package factor 83634-454-61 14 day patient kit containing : 1 - 14 mg per 2.8 ml multi-dose vial 14 - disposable syringes 28 - alcohol swabs 1 kit per carton",
    "adverseReactions": "leuprolide acetate injection contraindicated patients known hypersensitive gnrh , gnrh agonist analogs excipients leuprolide acetate injection : reports anaphylactic gnrh agonist analogs reported medical literature .",
    "indications_original": "Leuprolide acetate injection is indicated in the palliative treatment of advanced prostatic cancer.",
    "contraindications_original": "The recommended dose is 1 mg (0.2 mL or 20 unit mark) administered as a single daily subcutaneous injection. As with other drugs administered chronically by subcutaneous injection, the injection site should be varied periodically. Each 0.2 mL contains 1 mg of leuprolide acetate, sodium chloride for tonicity adjustment, 1.8 mg of benzyl alcohol as preservative and water for injection. The pH may have been adjusted with sodium hydroxide and/or acetic acid.\n\n                  Follow the pictorial directions on the reverse side of this package insert for administration.\n\n                  NOTE: As with all parenteral products, inspect the solution for discoloration and particulate matter before each use.",
    "warningsAndPrecautions_original": "Leuprolide acetate injection is a sterile solution supplied as follows:\n\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                           \n                              Leuprolide Acetate Injection\n                           \n                           \n                        \n                        \n                           \n                              NDC\n                           \n                           \n                              (1 mg per 0.2 mL)\n                           \n                           \n                              Package Factor\n                           \n                        \n                        \n                           83634-454-61\n\n                           14 Day Patient Administration Kit containing:\n                              \n                                 1 - 14 mg per 2.8 mL Multi-Dose Vial\n\n                                 14 - disposable syringes\n\n                                 28 - alcohol swabs\n\n                              \n                           \n                           1 kit per carton",
    "adverseReactions_original": "Leuprolide acetate injection is contraindicated in patients known to be hypersensitive to GnRH, GnRH agonist analogs or any of the excipients in leuprolide acetate injection: Reports of anaphylactic reactions to GnRH agonist analogs have been reported in the medical literature."
}